BioCentury
ARTICLE | Clinical News

Inavir laninamivir: Phase III started

February 20, 2012 8:00 AM UTC

Biota said that Daiichi Sankyo began a double-blind, placebo-controlled Phase III trial to evaluate 2 doses of Inavir laninamivir in 1,500 healthy family members of a patient with confirmed influenza ...